FOR IMMEDIATE RELEASE
November 16, 2009
News

ART’S-WAY MANUFACTURING ANNOUNCES CONTRACT FOR MODULAR SWINE FACILITY FOR THE UNIVERSITY OF GEORGIA



ARMSTRONG, Iowa, November 16, 2009 – Art’s Way Manufacturing, Inc. (NASDAQ: ARTW), announces its wholly owned subsidiary, Art’s Way Scientific, Inc. – Buildings For Science – will be providing 6 modular swine facilities for breeding, gestation, farrowing, nursery and finisher operations. The complex will be used to train undergraduate and graduate students in all aspects of swine production. Research projects will include trials on nutrition, physiology and meat quality. The contract is valued at approximately $1.3 million.

The facility, developed for the University of Georgia in association with the Office of University Architects and Department of Animal & Dairy Sciences, will have some unique environmental features. Methane gas generated on-site will be used to fire the boilers that treat animal wastes and minimize odors. Exhaust fans are being connected to a biofilter in order to increase air quality. Rain water will be captured and reused to help keep the animal buildings clean. Waste water from the process will be spread on adjoining fields for irrigation.

Dan Palmer, General Manager of Art’s Way Scientific said, “We are very pleased to have been awarded this contract. With swine, specific attention needs to be paid to the management of effective environmental conditions, cleanable surfaces ventilation, animal pens, manure management and the quantity and quality of food and water. Our unique and modular designs address all of these key issues.”

J. Ward McConnell, Jr., Executive Chairman of the Board, said, “I am gratified Art’s Way Scientific’s design, manufacturing, pricing and customer service was evaluated and chosen to construct this innovative research center. With this order and other opportunities we are bidding on, we are confident Art’s Way Scientific will continue to contribute to the Company’s overall revenue and income growth in 2009 and beyond. We continue to focus on exceeding our customers’ expectations and increasing shareholder value.”


About Art’s-Way Scientific, Inc. Buildings for Science:

Art’s Way Scientific, Inc. is a wholly owned subsidiary of Art’s Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal science, public health and security requirements. Art's Way Scientific custom designs, manufactures, delivers, and installs laboratories and research facilities to meet customers’ critical requirements.


About Art’s-Way Manufacturing, Inc.

Art's Way manufactures and distributes farm machinery niche products including animal feed processing equipment, sugar beet defoliators and harvesters, land maintenance equipment, crop shredding equipment, plows, hay and forage equipment and top and bottom drive augers.  After market service parts are also an important part of the Company's business.  We have two wholly owned subsidiaries.  Art's Way Vessels Inc. manufactures pressurized tanks and vessels; Art's Way Scientific Inc. manufactures modular animal confinement buildings and modular laboratories.

For More Information, Contact:         Jim Drewitz, Investor Relations

830-669-2466


Or visit the Company's website at  www.artsway-mfg.com

This news release includes “forward-looking statements” within the meaning of the federal securities laws.  In this release, forward-looking statements generally relate to: (i) the Company’s ability to meet its production schedule; (ii) the Company’s intent to focus on driving revenue, controlling costs and strengthening its balance sheet; (iii) the expected impact of worldwide economic conditions; and (iv) intent to monitor market opportunities; and (vi) the Company’s growth potential in its industry.  Statements of anticipated future results are based on current expectations and are subject to a number of risks and uncertainties, including but not limited to, quarterly fluctuations in results, customer demand for the Company’s products and acceptance of its product lines, current domestic and international economic conditions, the Company’s ability to manage growth, incorrect assumptions by management with respect to production cycles and market conditions, unexpected production delays and other risks detailed from time to time in the Company’s Securities and Exchange Commission filings.  Actual results may differ markedly from management’s expectations.  The Company cautions readers not to place undue reliance upon any such forward-looking statements.

-END-